Periodic Reporting for period 2 - CellularNanoMachines (Development of Stimuli-Responsive Nanoparticle-carrying T lymphocytes in the Fight against Cancer)

Cancer immunotherapy has been recently erected as the fourth pillar of treatment modalities, along with radiotherapy, surgery, and chemotherapy. Since 2010, numerous clinical trials infusing ex vivo expanded tumor-specific T lymphocytes have demonstrated tumor regression in...